BioCorRx Enters Partnership with Virtual Reality Medical Center

BioCorRx (OTCQB:BICX) revealed it entered a partnership with the Virtual Reality Medical Center to go forward with a study on the company’s recovery program and their naltrexone implant.

As quoted in the press release:
VRMC plans to conduct studies at its office in the Scripps Memorial Hospital Campus where they have access to the expertise and experience of the Scripps physicians and community. Drs. Mark and Brenda Wiederhold will be working closely with Dr. Joseph Shurman. VRMC has extensive experience in establishing Institutional Review Boards (IRB) and preparation of Investigational New Drug (IND) applications with the FDA, which it will bring to its partnership with BioCorRx. Additionally, VRMC has over 30 years of experience in applying for and securing government grants and contracts. VRMC plans to seek additional grant funding from the National Institutes of Health to support further clinical research related to BioCorRx’s naltrexone implant and recovery program.

Click here to read the full press release.

Source: www.accesswire.com